Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

× No keyword cloud information.

72 in total

1. Threshold analysis using diagnostic tests with multiple results.

Authors: R F Nease; D K Owens; H C Sox
Journal: Med Decis Making Date: 1989 Apr-Jun Impact factor: 2.583

2. Autoantibodies--diagnostic, pathogenic and prognostic relevance.

Authors: K Conrad; E M Tan; R L Humbel; Y Shoenfeld
Journal: Clin Exp Rheumatol Date: 1997 Jul-Aug Impact factor: 4.473

3. Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.

Authors: P B Chapman; A N Houghton
Journal: J Clin Invest Date: 1991-07 Impact factor: 14.808

4. Stimulation of peripheral blood lymphocytes with Campylobacter jejuni generates a gammadelta T cell response in patients with Guillain-Barrésyndrome.

Authors: A Ben-Smith; J C Goodall; J S Gaston; J B Winer
Journal: Clin Exp Immunol Date: 1997-07 Impact factor: 4.330

5. Ten steps in characterizing and diagnosing patients with peripheral neuropathy.

Authors: P J Dyck; P J Dyck; I A Grant; R D Fealey
Journal: Neurology Date: 1996-07 Impact factor: 9.910

6. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Authors: N Yuki; Y Tagawa; S Handa
Journal: J Neuroimmunol Date: 1996-10 Impact factor: 3.478

7. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome.

Authors: B C Jacobs; J Meulstee; P A van Doorn; F G van der Meché
Journal: Muscle Nerve Date: 1997-04 Impact factor: 3.217

8. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group.

Authors: L H Visser; F G Van der Meché; P A Van Doorn; J Meulstee; B C Jacobs; P G Oomes; R P Kleyweg; J Meulstee
Journal: Brain Date: 1995-08 Impact factor: 13.501

9. Guillain-Barré as an autoimmune disease.

Authors: Y Shoenfeld; J George; J B Peter
Journal: Int Arch Allergy Immunol Date: 1996-04 Impact factor: 2.749

10. Spontaneous recovery from the Guillain-Barré syndrome is associated with anti-idiotypic antibodies recognizing a cross-reactive idiotype on anti-neuroblastoma cell line antibodies.

Authors: I Lundkvist; P A van Doorn; M Vermeulen; A Brand
Journal: Clin Immunol Immunopathol Date: 1993-06